Impact of Chinese national centralized volume-based drug procurement policy on health costs and utilization: An interrupted time series analysis using panel data (2009–2022)

• Yishi Jiang,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing

  Affiliation NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

  ⨯
• Guangsheng Wan,

  Roles Validation, Writing – review & editing

  Affiliation College of Nursing and Health Management, Shanghai University of Medicine and Health Sciences, Shanghai, China

  ⨯
• Yufeng Shi,

  Roles Validation, Writing – review & editing

  Affiliation College of Nursing and Health Management, Shanghai University of Medicine and Health Sciences, Shanghai, China

  ⨯
• Guiping Pu,

  Roles Validation, Writing – review & editing

  Affiliation College of Nursing and Health Management, Shanghai University of Medicine and Health Sciences, Shanghai, China

  ⨯
• Xiaojun Shao

  Roles Conceptualization, Methodology, Validation, Writing – review & editing

  * E-mail: stevenschao@qq.com

  Affiliation College of Nursing and Health Management, Shanghai University of Medicine and Health Sciences, Shanghai, China

  https://orcid.org/0009-0009-9231-4202

  ⨯